Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression

Y Gong, UD Chippada-Venkata, WK Oh - Cancers, 2014 - mdpi.com
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in
the degradation of the extracellular matrix, play an important role in tissue remodeling …

Cancer prevention research—then and now

AM Bode, Z Dong - Nature Reviews Cancer, 2009 - nature.com
Throughout history, humankind has won the battle against deadly diseases, including small
pox and polio, by defeating them through prevention. Cancer prevention is a global priority …

Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study

SJ Freedland, WB Isaacs, EA Platz… - Journal of clinical …, 2005 - ascopubs.org
Purpose Prostate growth and differentiation are under androgenic control, and prior studies
suggested that tumors that develop in hypogonadal men are more aggressive. We …

Evidence for a biopsy derived grade artifact among larger prostate glands

GS Kulkarni, R Al-Azab, G Lockwood, A Toi… - The Journal of …, 2006 - auajournals.org
Purpose: The PCPT has demonstrated a higher incidence of high grade (Gleason pattern 4
or greater) prostate cancers among men randomized to finasteride. One plausible …

Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial

YC Cohen, KS Liu, NL Heyden… - Journal of the …, 2007 - academic.oup.com
Abstract Background The Prostate Cancer Prevention Trial (PCPT) demonstrated a 24.8%
reduction in the 7-year prevalence of prostate cancer among patients treated with finasteride …

Prostate volume and adverse prostate cancer features: fact not artifact

A Briganti, FKH Chun, N Suardi, A Gallina… - European journal of …, 2007 - Elsevier
PURPOSE: A recent prostate cancer finasteride chemoprevention trial showed a higher rate
of sextant biopsy-detected high grade prostate cancer (HGPCa) in finasteride exposed men …

[HTML][HTML] Fibronectin induces MMP2 expression in human prostate cancer cells

A Moroz, FK Delella, LM Lacorte, E Deffune… - Biochemical and …, 2013 - Elsevier
High-grade prostate cancers express high levels of matrix metalloproteinases (MMPs),
major enzymes involved in tumor invasion and metastasis. However, the tumor cell lines …

Update on chemoprevention of prostate cancer

EA Klein, IM Thompson - Current opinion in urology, 2004 - journals.lww.com
Results of a population-based, randomized phase III trial demonstrates that finasteride can
prevent prostate cancer. A large amount of data supports the use of other agents as potential …

[图书][B] Benefit-risk appraisal of medicines: A systematic approach to decision-making

F Mussen, S Salek, S Walker - 2009 - books.google.com
Benefit-risk assessment is at the centre of the approval process for every new medicine. The
ability to assess the risks of a new medicine accurately and to balance these against the …

Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation

A Moroz, FK Delella, R Almeida, LM Lacorte… - PLoS …, 2013 - journals.plos.org
Introduction The use of the 5-alpha reductase inhibitors (5-ARIs) finasteride and dutasteride
for prostate cancer prevention is still under debate. The FDA recently concluded that the …